Ann-Hwee Lee

Title: Innovations by Ann-Hwee Lee

Introduction

Ann-Hwee Lee is a prominent inventor based in Ardsley, NY (US). She has made significant contributions to the field of biotechnology, particularly in the development of multispecific binding molecules. With a total of 3 patents, her work focuses on innovative solutions for cancer treatment.

Latest Patents

Ann-Hwee Lee's latest patents include groundbreaking advancements in N-terminal scFv multispecific binding molecules. These multispecific binding molecules (MBMs) comprise an N-terminal scFv, a first Fab, and a second Fab. The patents also cover MBM conjugates that include cytotoxic or cytostatic agents, as well as pharmaceutical compositions containing the MBMs and MBM conjugates. Furthermore, her work outlines methods for using these MBMs, MBM conjugates, and pharmaceutical compositions for treating cancer. The patents also detail nucleic acids encoding the MBMs, cells engineered to express the MBMs, and methods for producing these innovative molecules.

Career Highlights

Ann-Hwee Lee is currently employed at Regeneron Pharmaceuticals, Inc., where she continues to push the boundaries of scientific research and innovation. Her work has been instrumental in advancing therapeutic options for patients suffering from cancer.

Collaborations

Throughout her career, Ann-Hwee Lee has collaborated with notable colleagues, including Yang Shen and Yan Yang. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in biotechnology.

Conclusion

Ann-Hwee Lee's contributions to the field of biotechnology, particularly through her patents on multispecific binding molecules, highlight her role as a leading inventor. Her work at Regeneron Pharmaceuticals, Inc. continues to pave the way for advancements in cancer treatment.